BillionToOne, Inc.
BLLN
주식 순위
#3440
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
주가
$103.00
시가총액
$4.86B
변동 (1일)
-1.60%
변동 (1년)
-
국가
US
거래 BillionToOne, Inc. (BLLN)
카테고리
Healthcare
BillionToOne, Inc. (BLLN)의 배당 수익률 기록
BillionToOne, Inc. (주식 심볼: BLLN)의 배당 수익률 (TTM)은 2024-12-31 기준으로 0.00%입니다.
지난 5년 평균 배당 수익률: 0.00%
지난 5년 평균 배당 수익률: 0.00%
BillionToOne, Inc. (BLLN)의 배당 수익률 기록: 2023 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
| 연도 | 배당 수익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
| 회사 | 배당 수익률 | 국가 |
|---|---|---|
| 0.27% |
US
|
|
| 0.65% |
US
|
|
| 0.00% |
US
|
|
| 1.48% |
CN
|
|
| 0.57% |
US
|
